[Angiotensin-converting enzyme inhibitors. Principles and rules of use].
Eicher
J C
JC
Centre de cardiologie clinique et interventionnelle, CHRU Le Bocage, 21034 Dijon.
Wolf
J E
JE
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000328:Adult; D000368:Aged; D000799:Angioedema / Q000139:chemically induced; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D003371:Cough / Q000139:chemically induced; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003928:Diabetic Nephropathies / Q000150:complications; D003875:Drug Eruptions / Q000209:etiology; D004347:Drug Interactions; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced; D007231:Infant, Newborn; D007676:Kidney Failure, Chronic / Q000139:chemically induced; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D011247:Pregnancy; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D012307:Risk Factors; D013651:Taste Disorders / Q000139:chemically induced; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors
Inhibiteurs de l'enzyme de conversion de l'angiotensine. Principes et règles d'utilisation.